Published in Oncogene on July 28, 2008
Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins. Curr Opin Cell Biol (2009) 2.61
A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma. Clin Cancer Res (2012) 0.99
Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target. Clin Cancer Res (2012) 0.98
O-linked N-acetylglucosamine cycling regulates mitotic spindle organization. J Biol Chem (2013) 0.98
Expanding the substantial interactome of NEMO using protein microarrays. PLoS One (2010) 0.97
Nucleophosmin/B23 activates Aurora A at the centrosome through phosphorylation of serine 89. J Cell Biol (2012) 0.95
A functional cooperativity between Aurora A kinase and LIM kinase1: implication in the mitotic process. Cell Cycle (2012) 0.91
PTTG1/securin modulates microtubule nucleation and cell migration. Mol Biol Cell (2011) 0.88
PTTG1 attenuates drug-induced cellular senescence. PLoS One (2011) 0.82
Systems genetic analysis of hippocampal neuroanatomy and spatial learning in mice. Genes Brain Behav (2015) 0.75
Altered expression of securin (Pttg1) and serpina3n in the auditory system of hearing-impaired Tff3-deficient mice. Cell Mol Life Sci (2010) 0.75
Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science (2001) 4.82
Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol (1997) 2.90
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet (2000) 2.39
A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab (2010) 2.33
Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab (2000) 2.27
Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, phase II trial. J Clin Endocrinol Metab (2010) 2.16
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet (2001) 2.08
Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci U S A (1999) 2.04
Schwann cells express motor and sensory phenotypes that regulate axon regeneration. J Neurosci (2006) 1.97
The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA (1997) 1.84
Three-dimensional optical coherence tomography of Barrett's esophagus and buried glands beneath neosquamous epithelium following radiofrequency ablation. Endoscopy (2009) 1.82
Clonal origin of pituitary adenomas. J Clin Endocrinol Metab (1990) 1.81
Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene (2012) 1.80
Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke (2004) 1.79
Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol (1999) 1.78
Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab (1998) 1.74
Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med (1999) 1.72
Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab (1999) 1.69
Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab (1998) 1.68
Colon polyps in acromegaly. Ann Intern Med (1991) 1.66
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab (2008) 1.66
Bedside end-tidal CO2 tension as a screening tool to exclude pulmonary embolism. Eur Respir J (2009) 1.63
Schwann cell phenotype is regulated by axon modality and central-peripheral location, and persists in vitro. Exp Neurol (2013) 1.62
Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Mol Endocrinol (2001) 1.61
Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid. J Clin Endocrinol Metab (1998) 1.48
Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environ Health Perspect (1998) 1.46
Discrimination of proximal hip fracture by quantitative ultrasound measurement at the radius. Osteoporos Int (2000) 1.46
Clinical, quality of life, and economic value of acromegaly disease control. Pituitary (2011) 1.44
Pituitary tumor registry: a novel clinical resource. J Clin Endocrinol Metab (2000) 1.41
Halotolerance of Methanobacterium thermoautotrophicum delta H and Marburg. J Bacteriol (1994) 1.39
Human fetal pituitary expresses functional growth hormone-releasing peptide receptors. J Clin Endocrinol Metab (1998) 1.38
Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China. Am J Hum Genet (2000) 1.37
Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. J Virol (1993) 1.36
Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG-0803). Ann Oncol (2012) 1.36
Pathophysiology of acromegaly. Endocr Rev (1983) 1.35
Arf family GTPases: roles in membrane traffic and microtubule dynamics. Biochem Soc Trans (2005) 1.33
Letter: Metoclopramide and facial dyskinesia. Br Med J (1975) 1.33
Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology (1998) 1.33
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr Rev (2000) 1.28
Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis. J Biol Chem (2000) 1.24
Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. J Clin Invest (2000) 1.23
Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. J Clin Endocrinol Metab (1981) 1.22
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
SPO14 separation-of-function mutations define unique roles for phospholipase D in secretion and cellular differentiation in Saccharomyces cerevisiae. Genetics (2001) 1.22
Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines. Adv Med Sci (2011) 1.21
Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab (1995) 1.21
Measurement and correlates of ano-genital distance in healthy, newborn infants. Int J Androl (2010) 1.21
Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency. Br J Cancer (1990) 1.20
Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis. Endocrinology (1998) 1.19
Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene. J Clin Endocrinol Metab (1999) 1.18
Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci U S A (1994) 1.18
Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. J Clin Invest (1999) 1.17
ROS1 fusions in Chinese patients with non-small-cell lung cancer. Ann Oncol (2013) 1.17
Human pituitary tumor-transforming gene induces angiogenesis. J Clin Endocrinol Metab (2001) 1.17
Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J Clin Invest (1996) 1.14
Identification and validation of a gene involved in anchorage-independent cell growth control using a library of randomized hairpin ribozymes. Genomics (2000) 1.11
Relative increase in insulin-like growth factor I messenger ribonucleic acid levels in compensatory renal hypertrophy. Endocrinology (1987) 1.11
Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion. Mol Endocrinol (1998) 1.11
Current management practices for acromegaly: an international survey. Pituitary (2011) 1.10
Pituitary cytokine and growth factor expression and action. Endocr Rev (1997) 1.10
Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis. Scand J Immunol (2010) 1.10
Lasp-1 is a regulated phosphoprotein within the cAMP signaling pathway in the gastric parietal cell. Am J Physiol (1998) 1.09
Somatotroph insulin-like growth factor-I signaling. Ann N Y Acad Sci (1993) 1.09
Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus. Int J Cancer (2001) 1.08
Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08
Management of pituitary tumors. Ann Intern Med (1998) 1.07
Clinical review 18: Are patients with acromegaly at increased risk for neoplasia? J Clin Endocrinol Metab (1991) 1.07
Tissue plasminogen activator (tPA) for ischemic stroke in patients aged ≥80 years. Acta Neurol Scand (2013) 1.07
Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J Clin Invest (1995) 1.07
Socio-economic factors affecting the success of tuberculosis treatment in six counties of Shandong Province, China. Int J Tuberc Lung Dis (2010) 1.06
The prevention of silicosis and prediction of its future prevalence in China. Am J Public Health (1989) 1.06
Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest (1997) 1.06
Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition. Oncogene (2007) 1.06
Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06
Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy. Circulation (1982) 1.05
Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: evidence from live cell imaging. Mol Endocrinol (2000) 1.05
Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Acta Radiol (2008) 1.04
Ovine neuronal ceroid lipofuscinosis: a large animal model syntenic with the human neuronal ceroid lipofuscinosis variant CLN6. J Med Genet (1998) 1.02
Prevalence of androgenetic alopecia in China: a community-based study in six cities. Br J Dermatol (2009) 1.01
Inositol-1-phosphate synthase from Archaeoglobus fulgidus is a class II aldolase. Biochemistry (2000) 1.01
Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. Endocrinology (1996) 1.01
Defocused imaging of second harmonic generation from a single nanocrystal. Opt Express (2007) 1.01
Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice. Cytotherapy (2007) 1.01
Overexpression of an isoform of AML1 in acute leukemia and its potential role in leukemogenesis. Leukemia (2009) 1.01
Molecular cloning of ERp29, a novel and widely expressed resident of the endoplasmic reticulum. FEBS Lett (1997) 1.01
Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study. J Clin Endocrinol Metab (1995) 1.00
Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling. J Biol Chem (1999) 1.00
Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. J Clin Endocrinol Metab (1994) 1.00
Kupfer-type immunological synapse characteristics do not predict anti-brain tumor cytolytic T-cell function in vivo. Proc Natl Acad Sci U S A (2010) 1.00
Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res (1995) 1.00
The central role of SOCS-3 in integrating the neuro-immunoendocrine interface. J Clin Invest (2001) 1.00
Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J Clin Endocrinol Metab (1994) 0.99
Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Clin Microbiol Infect (2013) 0.99
Insulinlike growth factor I regulation of growth hormone gene transcription in primary rat pituitary cells. J Clin Invest (1987) 0.99
Neuronal expression of the transcription factor Gli1 using the Talpha1 alpha-tubulin promoter is neuroprotective in an experimental model of Parkinson's disease. Gene Ther (2004) 0.99